EV/EBITDA
-1.94
-0.05-2.65%
16 min ago
Summary
- As of March 12, 2025, NTLA EV/EBITDA is -1.94, with a fall of -0.05 (-2.65%) during the most recent trading day.
- Over the past year, NTLA EV/EBITDA has increased by +3.15 (+61.89%).
- NTLA EV/EBITDA is now -4.86% below its all-time high of -1.85.
Performance
NTLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NTLA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.6% | +2.9% | +2.9% |
| 1 m1 month | -1.6% | +1.8% | +0.4% |
| 3 m3 months | +25.1% | -25.6% | -29.3% |
| 6 m6 months | +52.0% | -51.0% | -53.5% |
| ytdytd | +16.0% | -15.9% | -17.4% |
| 1 y1 year | +61.9% | -60.6% | -65.6% |
| 5 y5 years | +62.2% | +96.8% | -12.6% |
NTLA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.6% | -2.46 | +21.1% | |
| 3 m | 3-month | -1.85 | -4.9% | -2.59 | +25.1% |
| 6 m | 6-month | -1.85 | -4.9% | -4.49 | +56.8% |
| 1 y | 1-year | -1.85 | -4.9% | -5.24 | +63.0% |
| 3 y | 3-year | -1.85 | -4.9% | -21.62 | +91.0% |
| 5 y | 5-year | -1.85 | -4.9% | -72.04 | +97.3% |
| alltime | all time | -1.85 | -4.9% | -72.04 | +97.3% |
Intellia Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.94(-16.0%) |
| 2024 | -2.31(-57.4%) |
| 2023 | -5.42(-7.7%) |
| 2022 | -5.87(-82.5%) |
| 2021 | -33.56(+25.6%) |
| Date | Value |
|---|---|
| 2020 | -26.73(+286.3%) |
| 2019 | -6.92(+11.6%) |
| 2018 | -6.20(-12.9%) |
| 2017 | -7.12(+11.1%) |
| 2016 | -6.41 |
FAQ
- What is Intellia Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Intellia Therapeutics?
- What is NTLA EV/EBITDA year-to-date change?
- What is Intellia Therapeutics EV/EBITDA year-on-year change?
What is Intellia Therapeutics EV/EBITDA?
The current EV/EBITDA of NTLA is -1.94
What is the all time high EV/EBITDA for Intellia Therapeutics?
Intellia Therapeutics all-time high EV/EBITDA is -1.85
What is NTLA EV/EBITDA year-to-date change?
Intellia Therapeutics EV/EBITDA has changed by +0.37 (+16.02%) since the beginning of the year
What is Intellia Therapeutics EV/EBITDA year-on-year change?
Over the past year, NTLA EV/EBITDA has changed by +3.15 (+61.89%)